Noosa News
Demand for weight-loss treatments opens new markets for Tasmania’s poppy industry
A shortage of the weight-loss drug Ozempic to treat type 2 diabetes has opened up new markets for the Tasmanian alkaloid poppy sector.
It’s the shot in the arm northern Tasmanian pharmaceutical business Extractas Bioscience needed.
For nearly a decade the poppy processor has struggled with a…
Continue Reading
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Noosa News21 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General21 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business23 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock